Publicaciones en las que colabora con Jesús Castilla Catalán (17)

2024

  1. COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022

    Eurosurveillance, Vol. 29, Núm. 13

2023

  1. Assessment of Knowledge and Attitudes Over Time in Postacute COVID-19 Environments: Protocol for an Epidemiological Study

    JMIR Research Protocols, Vol. 12, Núm. 1

  2. Effect of COVID-19 vaccination on the SARS-CoV-2 transmission among social and household close contacts: A cohort study

    Journal of Infection and Public Health, Vol. 16, Núm. 3, pp. 410-417

  3. Effectiveness of hepatitis C antiviral treatment and feasibility of hepatitis C elimination goal

    Postgraduate Medicine, Vol. 135, Núm. 4, pp. 352-360

  4. Infecciones, hospitalizaciones y mortalidad por COVID-19 en Navarra entre febrero de 2020 y septiembre de 2022

    Anales del sistema sanitario de Navarra, Vol. 46, Núm. 2, pp. 61-70

  5. Infección, hospitalización y mortalidad por COVID-19 en Navarra, febrero de 2020 a septiembre de 2022

    Anales del sistema sanitario de Navarra, Vol. 46, Núm. 1

  6. Risk reduction of hospitalisation and severe disease in vaccinated COVID-19 cases during the SARS-CoV-2 variant Omicron BA.1-predominant period, Navarre, Spain, January to March 2022

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 28, Núm. 5

  7. Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 28, Núm. 47

  8. Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 28, Núm. 47

2022

  1. Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants

    Microbiology Spectrum, Vol. 10, Núm. 2

  2. Effectiveness of influenza vaccination in preventing influenza in primary care, Navarre, Spain, 2021/22

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 27, Núm. 26

  3. Epidemiologic Features and Control Measures during Monkeypox Outbreak, Spain, June 2022

    Emerging Infectious Diseases, Vol. 28, Núm. 9, pp. 1847-1851

  4. Seroprevalence of antibodies against SARS-CoV-2 and risk of COVID-19 in Navarre, Spain, May to July 2022

    Eurosurveillance, Vol. 27, Núm. 33

2021

  1. Independent Role of Severe Obesity as a Risk Factor for COVID-19 Hospitalization: A Spanish Population-Based Cohort Study

    Obesity, Vol. 29, Núm. 1, pp. 29-37

  2. Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021

    Eurosurveillance, Vol. 26, Núm. 39

  3. Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 26, Núm. 29

2018

  1. Progress in the elimination of hepatitis C virus infection: A population-based cohort study in Spain

    PLoS ONE, Vol. 13, Núm. 12